Purchase Order W91YTZ23P0137

Award Date 10/1/23
Potential Completion Date 9/30/28
Potential Value $5.8M
Funding Federal Agency
Defense Health Agency
Contracting Federal Agency
Medical Command
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Fort Meade, MD 20755, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $18,609.00 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of HYPERRAB 300UNIT/ML 1S medical supplies, with a period of performance through April 10, 2024. This contract award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical,...
This is a $289,339.51 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of various pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military healthcare programs globally. The award is part of a larger $999,999,999 Indefinite Delivery...
This is a delivery order under a larger Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The contract, valued up to $999,999,999 through December 2025, provides a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. The specific delivery order, valued at $22,505.40, is for 4,565,424,924 units...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides for the delivery of allergy relief tablets to the Defense Logistics Agency (DLA). The $1,503.94 firm fixed-price delivery order, awarded on March 13, 2025, has an ultimate completion date of March 14, 2025. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $26,953.50 firm-fixed-price delivery order is for the medical product HYPERRAB 300UNIT/ML 1S. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical...
This is a $10,532.44 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is not designated as a set-aside. The award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distributor and healthcare solutions provider. The $11,252.70 firm fixed-price delivery order is for the supply of 4566484813 HYPERRAB 300 UNIT/ML VIAL 5ML medical products, with a completion date of December 11, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This is a $26,008.83 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA), a component of the Department of Defense, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of January 30, 2025 and is not designated as a set-aside. The contract provides a comprehensive range of pharmaceutical products, medical supplies, prescription medications, vaccines, and medical...
This is a $7,863.34 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is not designated as a set-aside. The award is part of a larger $999,999,999 indefinite delivery contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which covers a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally....
This is a $31,825.80 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not designated with a set-aside requirement. The contract provides a range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple...

This $5,815,182.20 firm fixed price purchase order was awarded by the Defense Health Agency to Jubilant Hollisterstier LLC, a pharmaceutical contract manufacturer, to provide venom immunotherapy supplies and related products to support the U.S. Army's allergy treatment programs from October 2023 through September 2028. The contract was originally solicited as an unrestricted procurement to supply freeze dried venom, dog hair allergens, and histamine products to the Army's Centralized Allergen Extract Laboratory at Fort Meade, Maryland. No set-aside was used for this award. Jubilant Hollisterstier has also received over $380 million in cooperative agreement grants from the Department of Health and Human Services and the Army to expand its domestic manufacturing capabilities for medical countermeasures and COVID-19 response efforts.

Generated 5/12/25, 10:07 AM